- 米国企業
- 10x Genomics, Inc.
10x Genomics, Inc.TXG
時価総額
$31.7億
PER
| 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
| Revenue | 246 | 299 | 490 | 516 | 619 |
| Cost of revenue | 61 | 58 | 74 | 120 | 209 |
| Gross profit | 185 | 240 | 416 | 396 | 409 |
| Research and development | 83 | 123 | 212 | 266 | 270 |
| In-process research and development | - | 448 | - | - | - |
| In-process research and development | - | - | - | - | 61 |
| Selling, general and administrative | 131 | 202 | 258 | 298 | 343 |
| Accrued contingent liabilities | 2 | 1 | -1 | - | - |
| Total operating expenses | 215 | 775 | 469 | 564 | 675 |
| Loss from operations | -31 | -534 | -52 | -168 | -265 |
| Interest income | 3 | 2 | 0 | 7 | 17 |
| Interest expense | 3 | 2 | 1 | 0 | 0 |
| Other expense, net | -0 | 1 | -1 | -0 | -0 |
| Loss on extinguishment of debt | - | -2 | - | - | - |
| Total other income (expense) | -0 | -0 | -1 | 6 | 17 |
| Total other income (expense) | -0 | -0 | -1 | 6 | 17 |
| Loss before provision for income taxes | -31 | -534 | -54 | -162 | -249 |
| Provision for income taxes | 0 | 8 | 5 | 4 | 6 |
| Net loss | -31 | -543 | -58 | -166 | -255 |
| Earnings Per Share, Basic | - | - | -0.53 | -1.46 | -2.18 |
| Earnings Per Share, Diluted | - | - | -0.53 | -1.46 | -2.18 |